Showing results (31-40 of 284) with videos related to
Sort By:
Pageof 29
Neurochemical Research|October 26, 2006
Alzheimer disease--no target for statin treatment. A mini reviewSiegfried Hoyer, Peter RiedererJournal of Neural Transmission (Vienna, Austria : 1996)|June 17, 2023
The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson's diseaseThomas Müller, Peter RiedererJournal of Neural Transmission (Vienna, Austria : 1996)|March 24, 2018
Monoamine oxidase-B inhibitors in the treatment of Parkinson's disease: clinical-pharmacological aspectsPeter Riederer, Thomas MüllerExpert Opinion on Drug Metabolism & Toxicology|December 22, 2016
Use of monoamine oxidase inhibitors in chronic neurodegenerationPeter Riederer, Thomas MüllerParkinsonism & Related Disorders|November 19, 2008
Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's diseaseEleni Koutsilieri, Peter RiedererJournal of Neural Transmission (Vienna, Austria : 1996)|October 10, 2014
Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's diseaseEdna Grünblatt, Peter RiedererPharmacoeconomics|January 19, 2006
Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in GermanyGerd Laux, Bart Heeg, Ben A van Hout, et al.Psychiatrische Praxis|September 18, 2003
[Violence by Psychiatric In-Patients of the BZK Gabersee - First Results of a Standardized Documentation]Martin Finzel, Richard Schmidmeier, Miriam Fric, et al.Psychiatrische Praxis|September 26, 2003
[Aggression of psychiatric patients--first results of a standardized documentation at the Gabersee district hospital]Martin Finzel, Richard Schmidmeier, Miriam Fric, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 25, 2023
The 'α-synucleinopathy syndicate': multiple system atrophy and Parkinson's diseaseJeswinder Sian-Hulsmann, Peter RiedererPageof 29